Sleep and Breathing

, Volume 20, Issue 4, pp 1363–1366 | Cite as

Can treatment with statins have a negative influence on the tolerance of mandibular advancement devices?

  • Mónica González
  • Emilio Macias-Escalada
  • Juan Cobo
  • Maria Pilar Fernández Mondragón
  • Gerardo Gómez-Moreno
  • Marian Martínez-Martínez
  • Felix de Carlos
Dentistry • Short Communication

Abstract

Background

Statins are considered the most effective drugs used in the treatment of dyslipidemias. Some of their adverse effects are related to muscle problems. Myalgias produced by statins appear more often during exercise. Mandibular advancement devices (MAD) force the propulsory and elevatory musculature of the mandible to exercise by making the jaw move forward. The aim of this study is to evaluate the incidence of muscular side effects (referred, spontaneous, or under palpation pain, myofascial pain, mandibular rigidity and fatigue, tension and sensitivity of the masticatory muscles) in a group of patients with a diagnosis of obstructive sleep apnea being treated with MAD.

Methods

This was a prospective study, involving consecutively 104 patients with a diagnosis of OSAS, and who had begun treatment with a custom made oral device. Muscular side effects were collected by anamnesis (verbal request and questionnaires), psychological status and clinical assessment (manual muscle palpation in the masticatory and cervical muscle groups), before and during MAD treatment.

Results

Of the total sample, 22.1 % presented muscular side effects with the oral device. However, in patients taking statins, this percentage was 57.1 %, as opposed to 16.7 % of the non-statins patients (p < 0.001). The risk of suffering muscular alterations during oral device treatment is higher in statin patients (odds ratio 6.67, p = 0.002).

Conclusion

Treatment with statins can give rise to the appearance of undesirable side effects among patients being treated with oral devices.

Keywords

Dyslipidemias Statins Myotoxicity Sleep apnea Mandibular advancement devices 

Notes

Acknowledgments

Our thanks to Pedro Muñoz, epidemiologist of the Cantabrian Health Service for his help with the statistical analysis.

Compliance with ethical standards

Funding

No funding was received for this reached

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants; participation in speakers bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

References

  1. 1.
    Iwere RB, Hewitt J (2015) Myopathy in older people receiving statin therapy: a systematic review and metaanalysis. Br J Clin Pharmacol 80:363–371CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Banach M, Rizzo M, Toth PP, et al. (2015) Statin intolerance—an attempt at unified definition. Position paper from an international lipid expert panel. Arch Med Sci 11:1–23CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Taylor BA, Thompson PD (2015) Muscle related side effects of statins from mechanisms to evidence-based solutions. Curr Opin Lipidol 26:221–227CrossRefPubMedGoogle Scholar
  4. 4.
    Stroes ES, Thompson PD, Corsini A, et al. (2015) Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 36:1012–1022CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Sutherland K, Deane SA, Chan ASL, Schwab RJ, Ng AT, Darendeliler MA, Cistulli PA (2011) Comparative effects of two oral appliances on upper airway structure in obstructive sleep apnea. Sleep 34(4):469–477CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Sutherland K, Vanderveken O, Tsuda H, et al. (2014) Oral appliance treatment for obstructive sleep apnea: an update. J Clin Sleep Med 10:215–227PubMedPubMedCentralGoogle Scholar
  7. 7.
    Doff MH, Veldhuis SK, Hoekema A, Slater JJ, Wijkstra PJ, de Bont LG, Stegenga B (2012) Long-term oral appliance therapy in obstructive sleep apnea syndrome a controlled study on temporomandibular side effects. Clin Oral Investig 16:689–697CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Mónica González
    • 1
  • Emilio Macias-Escalada
    • 2
  • Juan Cobo
    • 2
  • Maria Pilar Fernández Mondragón
    • 3
  • Gerardo Gómez-Moreno
    • 4
  • Marian Martínez-Martínez
    • 1
  • Felix de Carlos
    • 2
  1. 1.Sleep and Ventilation Unit, Respiratory DivisionMarqués de Valdecilla University HospitalSantanderSpain
  2. 2.Department of Surgery and Medical-Surgical Specialties, Area of OrthodonticsFaculty of Medicine, University of OviedoOviedoSpain
  3. 3.Department of Stomatology IFaculty Of Odontology, Basque CountryVizcayaSpain
  4. 4.Department of Special Care in Dentistry, Pharmacological Research in DentistryFaculty of Dentistry, University of GranadaGranadaSpain

Personalised recommendations